ZYBERNO
Stock Report
Updated Sep 1, 2026

MARPAI, INC. (MRAI)

Healthcare • OTC

$2.36

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
7.0/100
POOR BUSINESS
MARPAI, INC. (MRAI) scores 7/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-81.8%)
Return on Capital (Capital Efficiency):CRITICAL (-109.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

MARPAI, INC. (MRAI) stock report — Zyberno Score 7/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.36
Market Cap:$61.03M

Valuation Multiples (2)

P/S Ratio:3.67x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$83.67M

Price Action & Momentum (1)

% of 52-Week High:94.4%
B. Profitability Assessment

Return Metrics (4)

ROA:-153.4%
Reinvestment Rate:8.6%
Fundamental Growth Rate (g):-9.4%

Margin Analysis (3)

Operating Margin Ttm:-81.8%
Net Margin Ttm:-101.5%
Ebitda Margin:-73.8%

TTM Performance (2)

Operating Margin Ttm:-81.8%
Net Margin Ttm:-101.5%

Yield Metrics (2)

Earnings Yield:-$35.16
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:23.4%
Latest Earnings Filed:2026-08-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-18.5%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.38x
Quick Ratio:0.38x
Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-3.76x
Times Interest Earned:-3.76

Capital Structure (4)

Working Capital:-14,542,000.00
Cash And Cash Equivalents:138,000.00
Long Term Debt:$18.28M
Net Debt:$22.64M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $16.64M
Linear Growth: -18.5%
📊 Click to view full MRAI Revenue analysis & methodology →
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$13.61M

Bottom Line Performance (3)

-$16.89M
Income Before Tax:-$16.89M
Ebitda Ttm:-12,283,000.00

Operating Expenses (5)

Operating Expenses:30,248,000.00
R And D Expense:7,000.00
Sga Expense:11,572,000.00
Income Tax Expense:-$150.00K
Interest Expense:3,604,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.2%
Sga To Revenue Percentage:277.8%
Ebitda Margin:-73.8%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$9.47M
Current Assets:$9.00M
Ppe Net:514,000.00
Goodwill:0.00
Intangible Assets:$5.18M

Liability Structure (4)

Total Liabilities:48,358,000.00
Current Liabilities:23,546,000.00
Long Term Debt:$18.28M
Short Term Debt:$4.50M

Equity & Capital (3)

Equity:-$38.89M
Retained Earnings:-$123.16M
Common Stock:227,791,050.00

Working Capital Items (3)

Accounts Receivable:1,017,000.00
Inventory:0.00
Accounts Payable:5,783,000.00

Special Items (2)

Contract Liabilities:317,000.00
Stock Based Compensation:203,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$7.82M$0.00

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$160.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:7,030,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:1,330,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.77
-$0.77
Earnings Per Share Ttm:-$0.65

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.64
Operating Cash Flow Per Share:-$0.29

Book Value & Capital (2)

Book Value Per Share:-$1.50
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.51x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:16.36x
Days Sales Outstanding Ttm:22.31

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:126.89
Cash Conversion Cycle:-1,103.57
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:0.00
Quality Score:15.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:8.6%
Fundamental Growth Rate (g):-9.4%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-18.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:MRAI
Company Name:MARPAI, INC.
Sector:Healthcare
Industry:Services-Misc Health & Allied Services, NEC
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:25.86M
Shares Outstanding Basic:25.86M
Shares Outstanding Diluted:25.86M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 14:29:09 UTC
Data Timestamp:2026-08-21T12:13:35.785606
Scroll to Top